Particle.news

Business ❯Pharmaceuticals ❯Drug Companies ❯Novartis

Acquisition

Novartis Acquires MorphoSys for $2.9 Billion, Expanding Cancer Drug Portfolio

Terms of Service Privacy Policy Jobs Help Partners About Us

Copyright © 2025 Mina Labs Inc.